+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Meningococcal Vaccines Market Size, Share & Trends Analysis Report By Brand (Menactra, Menveo), By Type, By Serotype, By Age Group, By Sales Channel, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 163 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 5595856
Description Jump to:
The global meningococcal vaccines market size is expected to reach USD 5.28 billion by 2030, registering a CAGR of 6.0% over the forecast period. Increasing prevalence of meningitis is one of the major factors attributed to the market growth. For instance, according to ECDC, it was estimated that in 2017, 3,221 confirmed cases were observed in EU member states, wherein 58% cases were found in the U. K., France, Spain, and Germany. Moreover, a high incidence of meningitis disease is found in the “meningitis belt” of sub-Saharan Africa, and approximately 30,000 cases are reported every year in this region.

In addition, rising FDA approval for meningococcal vaccines is expected to boost the growth. For instance, in April 2020, Sanofi received FDA approval for its MenQuadfi Meningococcal Conjugate Vaccine for the prevention of invasive meningococcal disorders in individuals at least two years old. The increase in approval of novel vaccines is expected to improve meningococcal prevention which in turn, is anticipated to drive the market.

Initiatives undertaken by the government to combat the rising incidence of the disease are anticipated to boost the meningococcal vaccine market growth. For instance, from April 2019, Nimenrix was made available for free as a part of the National Immunization Program (NIP) in Australia for the age group 15 to 19 years. Nimenrix is a quadrivalent meningococcal vaccine that targets serogroups A, C, W & Y.

According to WHO, as of 2021, 24 of the 26 nations in the meningitis belt have introduced mass preventive campaigns targeting the age of 1 to 29 years. Moreover, around 13 nations have undertaken the vaccine in their national routine immunization programs. Such initiatives undertaken by countries having high disease burdens are expected to boost the market growth.

Non-profit organizations entering into strategic initiatives such as partnering, alliances, and others to improve access to new vaccines for vulnerable children are anticipated to drive the market. For instance, in September 2021, WHO and its partners announced the first-ever global strategy to defeat meningitis. This initiative aims to reduce epidemics of bacterial meningitis. Under this strategy, WHO goals to save more than 200,000 lives annually.

The availability of vaccines at lower prices in countries with an increasing prevalence of the meningococcal disease is anticipated to fuel the revenue of the manufacturers and drive the meningococcal vaccine market. For instance, under Meningitis Vaccine Project, MenAfriVac costs less than USD 0.5 per dose.

Meningococcal Vaccines Market Report Highlights

  • Quadrivalent vaccines dominated for the largest revenue share of 51.1% in 2022 in type segment owing to their ability to target four serogroups and the strong presence of vaccines such as Menveo, Menactra, and Nimenrix
  • The infants (0-2 years) segment is expected to be the fastest-growing segment over the forecast period. The increasing prevalence of meningitis in the age group 9 months to 11 years contributed to the segment growth
  • Asia Pacific region is expected to witness the highest CAGR over the forecast period. High unmet needs, rising healthcare expenditure, and a large population base in this region are likely to bolster the market

Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List Of Secondary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Meningococcal Vaccines Market Variables, Trends, And Scope
3.1 Penetration And Growth Prospect Mapping
3.2 Product Pipeline Analysis
3.3 Regulatory Framework
3.3.1 North America
3.3.2 Europe
3.3.3 Asia Pacific
3.3.4 Latin America
3.3.5 Middle East & Africa
3.4 Market Driver Analysis
3.4.1 Rising Incidence Of Meningitis
3.4.2 Rising R&D In Meningococcal Vaccines
3.4.3 Increasing Immunization Programs And Government Initiatives
3.4.4 Growing Support By Healthcare Services In Providing Low-Cost Meningococcal Vaccine
3.5 Market Restraint Analysis
3.5.1 High Cost Associated With Storage And Supply Of Vaccines
3.5.2 Challenges Associated With Vaccine Development
3.6 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
3.7 Porter’s Five Forces Analysis
3.8 Major Deals And Strategic Alliances Analysis
3.8.1 New Product Launches
3.8.2 Mergers And Acquisitions
3.8.3 Expansion
3.8.4 Partnerships
3.8.5 Marketing And Promotions
3.8.6 Market Entry Strategies
Chapter 4 Meningococcal Vaccines Market: Segment Analysis, By Type, 2018 - 2030 (USD Million)
4.1 Definition And Scope
4.2 Type Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Global Meningococcal Vaccines Market, By Type, 2018 To 2030
4.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
4.5.1 Bivalent
4.5.1.1 Bivalent Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.5.2 Quadrivalent
4.5.2.1 Quadrivalent Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.5.3 Others
4.5.3.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 5 Meningococcal Vaccines Market: Segment Analysis, By Brand, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
5.1 Definition And Scope
5.2 Brand Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global Meningococcal Vaccines Market, By Brand, 2018 To 2030
5.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
5.5.1 Menactra
5.5.1.1 Menactra Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
5.5.2 Menveo
5.5.2.1 Menveo Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
5.5.3 Nimenrix
5.5.3.1 Nimenrix Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
5.5.4 Trumenba
5.5.4.1 Trumenba Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
5.5.5 Bexsero
5.5.5.1 Bexsero Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
5.5.6 Others
5.5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
Chapter 6 Meningococcal Vaccines Market: Segment Analysis, By Age Group, 2018 - 2030 (USD Million)
6.1 Definition And Scope
6.2 Age Group Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Global Meningococcal Vaccines Market, By Age Group, 2018 To 2030
6.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
6.5.1 Infants (0-2 Years)
6.5.1.1 Infants Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2 Children And Adults (2 Years And Above)
6.5.2.1 Children And Adults Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 7 Meningococcal Vaccines Market: Segment Analysis, By Serotype, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
7.1 Definition And Scope
7.2 Serotype Market Share Analysis, 2022 & 2030
7.3 Segment Dashboard
7.4 Global Meningococcal Vaccines Market, By Serotype, 2018 To 2030
7.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
7.5.1 Serotype A
7.5.1.1 Serotype A Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
7.5.2 Serotype B
7.5.2.1 Serotype B Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
7.5.3 Serotype C
7.5.3.1 Serotype C Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
7.5.4 Serotype W-135
7.5.4.1 Serotype W Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
7.5.5 Serotype Y
7.5.5.1 Serotype Y Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
Chapter 8 Meningococcal Vaccines Market: Segment Analysis, By Sales Channel, 2018 - 2030 (USD Million)
8.1 Definition And Scope
8.2 Sales Channel Market Share Analysis, 2022 & 2030
8.3 Segment Dashboard
8.4 Global Meningococcal Vaccines Market, By Sales Channel, 2018 To 2030
8.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
8.5.1 Private
8.5.1.1 Private Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.2 Public
8.5.2.1 Public Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 9 Meningococcal Vaccines Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)
9.1 Definition & Scope
9.2 Regional Market Share Analysis, 2022 & 2030
9.3 Regional Market Dashboard
9.4 Regional Market Snapshot
9.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
9.5.1 North America
9.5.1.1 North America Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.1.2 U.S.
9.5.1.2.1 Key Country Dynamics
9.5.1.2.2 Competitive Scenario
9.5.1.2.3 Regulatory Framework
9.5.1.2.4 Reimbursement Scenario
9.5.1.2.5 U.S. Market Estimate And Forecasts, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.1.3 Canada
9.5.1.3.1 Key Country Dynamics
9.5.1.3.2 Competitive Scenario
9.5.1.3.3 Regulatory Framework
9.5.1.3.4 Reimbursement Scenario
9.5.1.3.5 Canada Market Estimate And Forecasts, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2 Europe
9.5.2.1 Europe Market Estimate And Forecasts, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.2 Germany
9.5.2.2.1 Key Country Dynamics
9.5.2.2.2 Competitive Scenario
9.5.2.2.3 Regulatory Framework
9.5.2.2.4 Reimbursement Scenario
9.5.2.2.5 Germany Market Estimate And Forecasts, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.3 Uk
9.5.2.3.1 Key Country Dynamics
9.5.2.3.2 Competitive Scenario
9.5.2.3.3 Regulatory Framework
9.5.2.3.4 Reimbursement Scenario
9.5.2.3.5 Uk Market Estimate And Forecasts, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.4 France
9.5.2.4.1 Key Country Dynamics
9.5.2.4.2 Competitive Scenario
9.5.2.4.3 Regulatory Framework
9.5.2.4.4 Reimbursement Scenario
9.5.2.4.5 France Market Estimate And Forecasts, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.5 Spain
9.5.2.5.1 Key Country Dynamics
9.5.2.5.2 Competitive Scenario
9.5.2.5.3 Regulatory Framework
9.5.2.5.4 Reimbursement Scenario
9.5.2.5.5 Spain Market Estimate And Forecasts, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.6 Italy
9.5.2.6.1 Key Country Dynamics
9.5.2.6.2 Competitive Scenario
9.5.2.6.3 Regulatory Framework
9.5.2.6.4 Reimbursement Scenario
9.5.2.6.5 Italy Market Estimate And Forecasts, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.7 Russia
9.5.2.7.1 Key Country Dynamics
9.5.2.7.2 Competitive Scenario
9.5.2.7.3 Regulatory Framework
9.5.2.7.4 Reimbursement Scenario
9.5.2.7.5 Russia Market Estimate And Forecasts, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.8 Belarus
9.5.2.8.1 Key Country Dynamics
9.5.2.8.2 Competitive Scenario
9.5.2.8.3 Regulatory Framework
9.5.2.8.4 Reimbursement Scenario
9.5.2.8.5 Belarus Market Estimate And Forecasts, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.9 Georgia
9.5.2.9.1 Key Country Dynamics
9.5.2.9.2 Competitive Scenario
9.5.2.9.3 Regulatory Framework
9.5.2.9.4 Reimbursement Scenario
9.5.2.9.5 Georgia Market Estimate And Forecasts, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.10 Moldova
9.5.2.10.1 Key Country Dynamics
9.5.2.10.2 Competitive Scenario
9.5.2.10.3 Regulatory Framework
9.5.2.10.4 Reimbursement Scenario
9.5.2.10.5 Moldova Market Estimate And Forecasts, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.11 Denmark
9.5.2.11.1 Key Country Dynamics
9.5.2.11.2 Competitive Scenario
9.5.2.11.3 Regulatory Framework
9.5.2.11.4 Reimbursement Scenario
9.5.2.11.5 Denmark Market Estimate And Forecasts, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.12 Sweden
9.5.2.12.1 Key Country Dynamics
9.5.2.12.2 Competitive Scenario
9.5.2.12.3 Regulatory Framework
9.5.2.12.4 Reimbursement Scenario
9.5.2.12.5 Sweden Market Estimate And Forecasts, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.2.13 Norway
9.5.2.13.1 Key Country Dynamics
9.5.2.13.2 Competitive Scenario
9.5.2.13.3 Regulatory Framework
9.5.2.13.4 Reimbursement Scenario
9.5.2.13.5 Norway Market Estimate And Forecasts, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.3 Asia Pacific
9.5.3.1 Asia Pacific Market Estimate And Forecasts, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.3.2 Japan
9.5.3.2.1 Key Country Dynamics
9.5.3.2.2 Competitive Scenario
9.5.3.2.3 Regulatory Framework
9.5.3.2.4 Reimbursement Scenario
9.5.3.2.5 Japan Market Estimate And Forecasts, 2018 - 2030 (USD Million) (Volume, Number Of Doses (In Thousands))
9.5.3.3 China
9.5.3.3.1 Key Country Dynamics
9.5.3.3.2 Competitive Scenario
9.5.3.3.3 Regulatory Framework
9.5.3.3.4 Reimbursement Scenario
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Product Pipeline
Table 4 CDC Vaccine Price List
Table 5 List of Key Emerging Companies /Technology Disruptors/Innovators
Table 6 North America Meningococcal Vaccines Market, By Country, 2018 - 2030 (USD Million)
Table 7 North America Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 8 North America Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 9 North America Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 10 North America Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 11 North America Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 12 U.S. Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 13 U.S. Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 14 U.S. Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 15 U.S. Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 16 U.S. Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 17 Canada Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 18 Canada Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 19 Canada Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 20 Canada Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 21 Canada Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 22 Europe Meningococcal Vaccines Market, By Country, 2018 - 2030 (USD Million)
Table 23 Europe Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 24 Europe Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 25 Europe Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 26 Europe Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 27 Europe Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 28 Germany Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 29 Germany Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 30 Germany Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 31 Germany Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 32 Germany Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 33 UK Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 34 UK Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 35 UK Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 36 UK Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 37 UK Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 38 France Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 39 France Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 40 France Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 41 France Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 42 France Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 43 Italy Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 44 Italy Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 45 Italy Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 46 Italy Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 47 Italy Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 48 Spain Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 49 Spain Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 50 Spain Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 51 Spain Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 52 Spain Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 53 Russia Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 54 Russia Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 55 Russia Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 56 Russia Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 57 Russia Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 58 Belarus Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 59 Belarus Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 60 Belarus Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 61 Belarus Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 62 Belarus Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 63 Georgia Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 64 Georgia Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 65 Georgia Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 66 Georgia Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 67 Georgia Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 68 Moldova Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 69 Moldova Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 70 Moldova Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 71 Moldova Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 72 Moldova Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 73 Denmark Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 74 Denmark Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 75 Denmark Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 76 Denmark Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 77 Denmark Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 78 Sweden Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 79 Sweden Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 80 Sweden Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 81 Sweden Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 82 Sweden Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 83 Norway Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 84 Norway Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 85 Norway Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 86 Norway Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 87 Norway Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 88 Asia Pacific Meningococcal Vaccines Market, By Country, 2018 - 2030 (USD Million)
Table 89 Asia Pacific Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 90 Asia Pacific Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 91 Asia Pacific Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 92 Asia Pacific Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 93 Asia Pacific Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 94 Japan Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 95 Japan Meningococcal Vaccines Market, By Brand 2018 - 2030 (USD Million)
Table 96 Japan Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 97 Japan Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 98 Japan Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 99 China Meningococcal Vaccines Market, By Product, 2018 - 2030 (USD Million)
Table 100 China Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 101 China Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 102 China Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 103 China Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 104 India Meningococcal Vaccines Market, By Product, 2018 - 2030 (USD Million)
Table 105 India Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 106 India Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 107 India Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 108 India Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 109 Australia Meningococcal Vaccines Market, By Product, 2018 - 2030 (USD Million)
Table 110 Australia Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 111 Australia Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 112 Australia Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 113 Australia Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 114 Singapore Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 115 Singapore Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 116 Singapore Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 117 Singapore Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 118 Singapore Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 119 South Korea Meningococcal Vaccines Market, By Type 2018 - 2030 (USD Million)
Table 120 South Korea Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 121 South Korea Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 122 South Korea Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 123 South Korea Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 124 Thailand Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 125 Thailand Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 126 Thailand Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 127 Thailand Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 128 Thailand Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 129 Vietnam Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 130 Vietnam Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 131 Vietnam Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 132 Vietnam Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 133 Vietnam Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 134 Malaysia Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 135 Malaysia Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 136 Malaysia Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 137 Malaysia Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 138 Malaysia Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 139 Indonesia Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 140 Indonesia Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 141 Indonesia Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 142 Indonesia Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 143 Indonesia Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 144 Kazakhstan Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 145 Kazakhstan Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 146 Kazakhstan Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 147 Kazakhstan Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 148 Kazakhstan Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 149 Kyrgyzstan Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 150 Kyrgyzstan Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 151 Kyrgyzstan Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 152 Kyrgyzstan Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 153 Kyrgyzstan Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 154 Armenia Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 155 Armenia Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 156 Armenia Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 157 Armenia Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 158 Armenia Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 159 Azerbaijan Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 160 Azerbaijan Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 161 Azerbaijan Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 162 Azerbaijan Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 163 Azerbaijan Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 164 Tajikistan Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 165 Tajikistan Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 166 Tajikistan Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 167 Tajikistan Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 168 Tajikistan Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 169 Turkmenistan Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 170 Turkmenistan Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 171 Turkmenistan Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 172 Turkmenistan Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 173 Turkmenistan Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 174 Uzbekistan Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 175 Uzbekistan Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 176 Uzbekistan Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 177 Uzbekistan Meningococcal Vaccines Market, By Serotype 2018 - 2030 (USD Million)
Table 178 Uzbekistan Meningococcal Vaccines Market, By Sales Channel 2018 - 2030 (USD Million)
Table 179 Latin America Meningococcal Vaccines Market, By Country, 2018 - 2030 (USD Million)
Table 180 Latin America Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 181 Latin America Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 182 Latin America Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 183 Latin America Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 184 Latin America Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 185 Brazil Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 186 Brazil Meningococcal Vaccines Market, By Brand 2018 - 2030 (USD Million)
Table 187 Brazil Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 188 Brazil Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 189 Brazil Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 190 Mexico Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 191 Mexico Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 192 Mexico Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 193 Mexico Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 194 Mexico Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 195 Argentina Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 196 Argentina Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 197 Argentina Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 198 Argentina Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 199 Argentina Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 200 Chile Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 201 Chile Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 202 Chile Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 203 Chile Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 204 Chile Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 205 Cuba Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 206 Cuba Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 207 Cuba Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 208 Cuba Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 209 Cuba Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 210 Ecuador Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 211 Ecuador Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 212 Ecuador Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 213 Ecuador Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 214 Ecuador Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 215 Peru Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 216 Peru Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 217 Peru Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 218 Peru Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 219 Peru Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 220 Colombia Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 221 Colombia Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 222 Colombia Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 223 Colombia Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 224 Colombia Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 225 Venezuela Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 226 Venezuela Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 227 Venezuela Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 228 Venezuela Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 229 Venezuela Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 230 Middle East & Africa Meningococcal Vaccines Market, By Country, 2018 - 2030 (USD Million)
Table 231 Middle East & Africa Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 232 Middle East & Africa Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 233 Middle East & Africa Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 234 Middle East & Africa Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 235 Middle East & Africa Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 236 Saudi Arabia Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 237 Saudi Arabia Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 238 Saudi Arabia Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 239 Saudi Arabia Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 240 Saudi Arabia Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 241 South Africa Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 242 South Africa Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 243 South Africa Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 244 South Africa Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 245 South Africa Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 246 UAE Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 247 UAE Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 248 UAE Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 249 UAE Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 250 UAE Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 251 Algeria Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 252 Algeria Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 253 Algeria Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 254 Algeria Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 255 Algeria Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 256 Egypt Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 257 Egypt Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 258 Egypt Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 259 Egypt Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 260 Egypt Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 261 Tunisia Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 262 Tunisia Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 263 Tunisia Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 264 Tunisia Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 265 Tunisia Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 266 Iran Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 267 Iran Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 268 Iran Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 269 Iran Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 270 Iran Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 271 Turkey Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 272 Turkey Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 273 Turkey Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 274 Turkey Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 275 Turkey Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 276 Iraq Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 277 Iraq Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 278 Iraq Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 279 Iraq Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 280 Iraq Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 281 Morocco Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 282 Morocco Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 283 Morocco Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 284 Morocco Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 285 Morocco Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
Table 286 Kuwait Meningococcal Vaccines Market, By Type, 2018 - 2030 (USD Million)
Table 287 Kuwait Meningococcal Vaccines Market, By Brand, 2018 - 2030 (USD Million)
Table 288 Kuwait Meningococcal Vaccines Market, By Age Group, 2018 - 2030 (USD Million)
Table 289 Kuwait Meningococcal Vaccines Market, By Serotype, 2018 - 2030 (USD Million)
Table 290 Kuwait Meningococcal Vaccines Market, By Sales Channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Meningococcal vaccines market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Meningococcal vaccines market snapshot
Fig. 10 Key market opportunities
Fig. 11 Meningococcal vaccines market driver impact
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 SWOT analysis, by factor (Political & legal, economic, and technological)
Fig. 14 Porter’s five forces analysis
Fig. 15 Strategy mapping
Fig. 16 Meningococcal vaccines market: Type movement analysis
Fig. 17 Meningococcal vaccines: Type segment dashboard
Fig. 18 Meningococcal vaccines market type outlook: Key takeaways
Fig. 19 Bivalent market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Quadrivalent market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Meningococcal vaccines market: Brand movement analysis
Fig. 23 Meningococcal vaccines: Brand segment dashboard
Fig. 24 Meningococcal vaccines market Brand outlook: Key takeaways
Fig. 25 Menactra market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 26 Menveo market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 27 Nimenrix market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 28 Trumenba market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 29 Bexsero market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 31 Meningococcal vaccines market: Age group movement analysis
Fig. 32 Meningococcal vaccines: Age group segment dashboard
Fig. 33 Meningococcal vaccines market age group outlook: Key takeaways
Fig. 34 Infants (0-2 years) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Children and adults (2 years and above) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Meningococcal vaccines market: Serotype movement analysis
Fig. 37 Meningococcal vaccines: Serotype segment dashboard
Fig. 38 Meningococcal vaccines market Serotype outlook: Key takeaways
Fig. 39 Serotype A market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 40 Serotype B market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 41 Serotype C market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 42 Serotype W-135 market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 43 Serotype Y market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 44 Meningococcal vaccines market: Sales channel movement analysis
Fig. 45 Meningococcal vaccines: Sales channel segment dashboard
Fig. 46 Meningococcal vaccines market Sales channel outlook: Key takeaways
Fig. 47 Private market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Public market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Regional outlook, 2019 & 2027
Fig. 50 Regional market dashboard
Fig. 51 Regional market place: Key takeaways
Fig. 52 North America SWOT analysis
Fig. 53 North America market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 54 U.S. key country dynamics
Fig. 55 U.S. market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 56 Canada key country dynamics
Fig. 57 Canada market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 58 Europe SWOT analysis
Fig. 59 Europe market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 60 Germany key country dynamics
Fig. 61 Germany market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 62 UK key country dynamics
Fig. 63 UK market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 64 France key country dynamics
Fig. 65 France market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 66 Spain key country dynamics
Fig. 67 Spain market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 68 Italy key country dynamics
Fig. 69 Italy market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 70 Russia key country dynamics
Fig. 71 Russia market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 72 Belarus key country dynamics
Fig. 73 Belarus market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 74 Georgia key country dynamics
Fig. 75 Georgia market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 76 Moldova key country dynamics
Fig. 77 Moldova market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 78 Denmark key country dynamics
Fig. 79 Denmark market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 80 Sweden key country dynamics
Fig. 81 Sweden market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 82 Norway key country dynamics
Fig. 83 Norway market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 84 Asia Pacific SWOT analysis
Fig. 85 Asia Pacific market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 86 Japan key country dynamics
Fig. 87 Japan market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 88 China key country dynamics
Fig. 89 China market estimate and forecasts, 2018 - 2030(Volume, Number of Doses (in Thousands))
Fig. 90 India key country dynamics
Fig. 91 India market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 92 South Korea key country dynamics
Fig. 93 South Korea market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 94 Australia key country dynamics
Fig. 95 Australia market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 96 Singapore key country dynamics
Fig. 97 Singapore market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 98 Thailand key country dynamics
Fig. 99 Thailand market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 100 Vietnam key country dynamics
Fig. 101 Vietnam market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 102 Malaysia key country dynamics
Fig. 103 Malaysia market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 104 Indonesia key country dynamics
Fig. 105 Indonesia market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 106 Kazakhstan key country dynamics
Fig. 107 Kazakhstan market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 108 Kyrgyzstan key country dynamics
Fig. 109 Kyrgyzstan market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 110 Armenia key country dynamics
Fig. 111 Armenia market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 112 Azerbaijan key country dynamics
Fig. 113 Azerbaijan market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 114 Tajikistan key country dynamics
Fig. 115 Tajikistan market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 116 Turkmenistan key country dynamics
Fig. 117 Turkmenistan market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 118 Uzbekistan key country dynamics
Fig. 119 Uzbekistan market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 120 Latin America SWOT analysis
Fig. 121 Latin America market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 122 Brazil key country dynamics
Fig. 123 Brazil market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 124 Mexico key country dynamics
Fig. 125 Mexico market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 126 Argentina key country dynamics
Fig. 127 Argentina market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 128 Chile key country dynamics
Fig. 129 Chile market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 130 Cuba key country dynamics
Fig. 131 Cuba market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 132 Ecuador key country dynamics
Fig. 133 Ecuador market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 134 Peru key country dynamics
Fig. 135 Peru market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 136 Colombia key country dynamics
Fig. 137 Colombia market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 138 Venezuela key country dynamics
Fig. 139 Venezuela market estimate and forecasts, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 140 Middle East & Africa SWOT analysis
Fig. 141 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 142 South Africa key country dynamics
Fig. 143 South Africa market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 144 Saudi Arabia key country dynamics
Fig. 145 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 146 UAE key country dynamics
Fig. 147 UAE market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 148 Algeria key country dynamics
Fig. 149 Algeria market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 150 Egypt key country dynamics
Fig. 151 Egypt market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 152 Tunisia key country dynamics
Fig. 153 Tunisia market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 154 Iran key country dynamics
Fig. 155 Iran market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 156 Turkey key country dynamics
Fig. 157 Turkey market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 158 Iraq key country dynamics
Fig. 159 Iraq market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 160 Morocco key country dynamics
Fig. 161 Morocco market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 162 Kuwait key country dynamics
Fig. 163 Kuwait market estimates and forecast, 2018 - 2030 (USD Million) (Volume, Number of Doses (in Thousands))
Fig. 164 Ansoff Matrix
Fig. 165 Competition Categorization
Fig. 166 Company market share analysis
Fig. 167 Company market position analysis
Fig. 168 Company market position analysis
Fig. 169 Competitive dashboard analysis
Fig. 170 Regional Network Map
Fig. 171 Strategy Framework

Companies Mentioned

  • Sanofi
  • Merck & Co., Inc.
  • Gsk Plc
  • Serum Institute Of India Pvt. Ltd.
  • Pfizer, Inc.
  • Walwax Biotechnology Co., Ltd
  • Petrovax

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages163
PublishedMay 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 3.28 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.28 Billion
Compound Annual Growth Rate6.0%
Regions CoveredGlobal
No. of Companies Mentioned7

Related Topics

Related Reports

Meningococcal Vaccine Market by Type, by Brand, by Age Group, by Serotype, by End-user, and by Region - Product Image

Meningococcal Vaccine Market by Type, by Brand, by Age Group, by Serotype, by End-user, and by Region

  • Report
  • 200 Pages
  • Global
From
Meningococcal Vaccines - Global Strategic Business Report - Product Image

Meningococcal Vaccines - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Meningococcal Vaccines Market Report by Vaccine Type, Composition, Vaccine Serotype, Distribution Channel, End User, and Region 2024-2032 - Product Image

Meningococcal Vaccines Market Report by Vaccine Type, Composition, Vaccine Serotype, Distribution Channel, End User, and Region 2024-2032

  • Report
  • 137 Pages
  • Global
From
Meningococcal Vaccines Market by Type, Category, Dosage Type, Target Group, End-User - Global Forecast 2025-2030 - Product Image

Meningococcal Vaccines Market by Type, Category, Dosage Type, Target Group, End-User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Meningococcal Vaccines Global Market Report 2024 - Product Image

Meningococcal Vaccines Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.